About the Authors
- Lindsay R. Ancelet
-
Affiliation Infectious Diseases Group, Malaghan Institute of Medical Research, Wellington, New Zealand
- Frank E. Aldwell
-
Affiliation Immune Solutions Ltd, Centre for Innovation, University of Otago, Dunedin, New Zealand
- Fenella J. Rich
-
Affiliation Infectious Diseases Group, Malaghan Institute of Medical Research, Wellington, New Zealand
- Joanna R. Kirman
-
* E-mail: jo.kirman@otago.ac.nz
Affiliation Department of Microbiology and Immunology, University of Otago, Dunedin, New Zealand
Competing Interests
FEA is an Inventor on a patent related to the Liporale technology and is a Director on a company (Immune Solutions Ltd) which has a vested interest in commercializing Liporale as an oral delivery platform. Liporale is covered by the following pending patents and applications: “Antigenic Compositions” WIPO WO/2003/009868 (PCT/NZ2002/00132, NZ 546141, AU 2002/326233, US 2004/0234533, EP 02760915.5, CA 2454920, ZA 2004/1211, CN 02817408.9, IN 00302/DELNP/2004, JP 2003-515260, HK 04109263.7. This study was partly commercially funded by Otago Innovations Ltd. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: LRA FEA JRK. Performed the experiments: LRA FJR. Analyzed the data: LRA JRK. Contributed reagents/materials/analysis tools: FEA. Wrote the paper: LRA JRK.